Sign in

CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company

Compass Therapeutics, Inc.

Sign in to watch
Ticker
CMPX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-500-8099
Business address
80 GUEST STREET, BOSTON, MA, 02135
Former names
Olivia Ventures, Inc.
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 4 Open-market buy Chief Accounting Officer bought 20,000 shares at $0.92 ($18,400)
  5. 4 Open-market buy Chief Accounting Officer bought 2,500 shares at $1.14 ($2,850)
  6. 8-K Event Regulation FD disclosure
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 8-K Event Regulation FD disclosure
  12. 8-K Event Bylaws or fiscal year change
  13. 8-K Event Shareholder vote results
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 4/A Open-market buy Chief Accounting Officer bought 15,000 shares at $1.89 ($28,350)
  18. 4/A Open-market buy General Counsel bought 25,000 shares at $1.89 ($47,250)
  19. 4 Grant or award General Counsel acquired 25,000 shares (grant or award)
  20. 4 Grant or award Chief Accounting Officer acquired 15,000 shares (grant or award)

Page 1 of 19 · 362 filings